Benedetto Filippo, Piffaretti Gabriele, Tozzi Matteo, Pipito' Narayana, Spinelli Domenico, Mariscalco Giovanni, Spinelli Francesco, Castelli Patrizio
Vascular Surgery, Department of Cardiovascular and Thoracic Sciences, G. Martino University Teaching Hospital, University of Messina School of Medicine, Messina, Italy.
Vascular Surgery, Department of Surgery and Morphological Sciences, Circolo University Teaching Hospital, University of Insubria School of Medicine, Varese, Italy.
Ann Vasc Surg. 2014 May;28(4):860-5. doi: 10.1016/j.avsg.2013.10.019. Epub 2013 Dec 24.
The purpose of this study was to compare midterm results of carotid-to-carotid bypass (CCB) after hybrid repair of aortic arch disease.
Between October 2001 and April 2012, all patients undergoing hybrid aortic arch repair with CCB were enrolled. CCBs were positioned in the subcutaneous or in the retropharyngeal position. Hybrid aortic arch repair was performed in a single-stage intervention.
We treated 19 (82.6%) men and 4 women; mean age was 74 ± 6 years (range, 58-83 years). Subcutaneous tunnelization was performed in 15 (65.5%) cases and the retropharyngeal route in 8 (34.5%). In-hospital mortality was 8.7% (n = 2); causes of death were major stroke (n = 1) and respiratory failure (n = 1). Cranial nerve injuries (transient or permanent), dysphagia, or local problems were not observed. Tracheostomy was never required. Early outcomes did not differ between the 2 types of bypass. Mean follow-up was 44 months (range, 1-118; median 24). Survival rate at 1, 3, and 5 years was 70% ± 9.6%, 55% ± 10.7%, and 50% ± 11.1%, respectively. At the time of the last follow-up control, all bypasses were patent: stenosis and thrombosis were not recorded. Bypass graft or endograft infection were not registered. Shrinkage of the aortic lesion was observed in 15 (71.4%) cases.
CCBs are durable at midterm follow-up. No relevant superiority was identified between the 2 types of CCB; subcutaneous and retropharyngeal routes proved to be equally safe.
本研究旨在比较主动脉弓疾病杂交修复术后颈动脉-颈动脉搭桥术(CCB)的中期结果。
2001年10月至2012年4月期间,纳入所有接受CCB杂交主动脉弓修复术的患者。CCB置于皮下或咽后位置。杂交主动脉弓修复术采用单阶段干预。
我们治疗了19名男性(82.6%)和4名女性;平均年龄为74±6岁(范围58 - 83岁)。15例(65.5%)采用皮下隧道化,8例(34.5%)采用咽后路径。住院死亡率为8.7%(n = 2);死亡原因是严重中风(n = 1)和呼吸衰竭(n = 1)。未观察到颅神经损伤(短暂或永久性)、吞咽困难或局部问题。从未需要气管切开术。两种类型的搭桥术早期结果无差异。平均随访44个月(范围1 - 118;中位数24)。1年、3年和5年生存率分别为70%±9.6%、55%±10.7%和50%±11.1%。在最后一次随访时,所有搭桥均通畅:未记录狭窄和血栓形成。未登记搭桥移植物或腔内移植物感染。15例(71.4%)观察到主动脉病变缩小。
CCB在中期随访中耐久性良好。两种类型的CCB之间未发现明显优势;皮下和咽后路径同样安全。